Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study
- PMID: 2297305
Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study
Abstract
The ability of botulinum A toxin to denervate and relax a spastic external urethral sphincter was evaluated in a double-blind study involving five men with high spinal cord injuries and detrusor-sphincter dyssynergia. The sphincter was injected with either a low dose of botulinum A toxin or normal saline once per week for three weeks. Electromyography of the external urethral sphincter indicated denervation in the three patients who received toxin injections. The urethral pressure profile decreased an average of 25cm of water, postvoiding residual volume of urine decreased an average of 125cc, and bladder pressure during voiding decreased to an average of 30cm of water. Bulbosphincteric reflexes were more difficult to obtain, and they showed a decreased amplitude with normal latency. In the two patients who received normal saline injections, parameters were unchanged from baseline values until subsequent injection with botulinum A toxin once per week for three weeks when their responses were similar to those of the other three patients. Mild generalized weakness lasting two to three weeks was noted by three patients after initial toxin injections. The duration of the toxin's effect averaged two months. The results suggest that botulinum A toxin, an inhibitor of acetylcholine release at the neuromuscular junction, may be useful in the treatment of detrusor-sphincter dyssynergia.
Similar articles
-
Effect of single botulinum toxin A injection to the external urethral sphincter for treating detrusor external sphincter dyssynergia in spinal cord injury.J Rehabil Med. 2008 Oct;40(9):744-8. doi: 10.2340/16501977-0255. J Rehabil Med. 2008. PMID: 18843427
-
Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients.J Urol. 1988 May;139(5):919-22. doi: 10.1016/s0022-5347(17)42717-0. J Urol. 1988. PMID: 3361663
-
The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.J Urol. 2007 Oct;178(4 Pt 2):1775-9; discussion 1779-80. doi: 10.1016/j.juro.2007.03.185. Epub 2007 Aug 17. J Urol. 2007. PMID: 17707430
-
Botulinum toxin as a new therapy option for voiding disorders: current state of the art.Eur Urol. 2003 Aug;44(2):165-74. doi: 10.1016/s0302-2838(03)00250-1. Eur Urol. 2003. PMID: 12875934 Review.
-
Botulinum toxin for the treatment of lower urinary tract symptoms: a review.Neurourol Urodyn. 2005;24(1):2-12. doi: 10.1002/nau.20090. Neurourol Urodyn. 2005. PMID: 15578628 Review.
Cited by
-
The Efficacy and Safety of Intrasphincteric Botulinum Toxin-A Injections in Patients with Non-Spinal Cord Injury-Related Detrusor Sphincter Dyssynergia: A Retrospective Study.Biomedicines. 2023 Nov 10;11(11):3016. doi: 10.3390/biomedicines11113016. Biomedicines. 2023. PMID: 38002018 Free PMC article.
-
Botulinum toxin: poisoning the spastic bladder and urethra.Rev Urol. 2002 Spring;4(2):61-8. Rev Urol. 2002. PMID: 16985657 Free PMC article.
-
Botulinum neurotoxin: evolution from poison, to research tool--onto medicinal therapeutic and future pharmaceutical panacea.Neurotox Res. 2007 Dec;12(4):275-90. doi: 10.1007/BF03033911. Neurotox Res. 2007. PMID: 18201955 Review.
-
Neurogenic bladder: from diagnosis to management.Curr Urol Rep. 2014 Oct;15(10):448. doi: 10.1007/s11934-014-0448-8. Curr Urol Rep. 2014. PMID: 25118855 Review.
-
A case for botulinum toxin-A in idiopathic bladder overactivity.Curr Urol Rep. 2004 Dec;5(6):432-6. doi: 10.1007/s11934-004-0066-y. Curr Urol Rep. 2004. PMID: 15541211 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical